Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Ugeskrift for Laeger
|
April 29, 2021
[Hypersexuality]
Katja Wium Geiker, Annamaria Giraldi, Karl Sebastian Johansson, et al.
Expert Opinion on Pharmacotherapy
|
February 29, 2020
Clinical pharmacology of imeglimin for the treatment of type 2 diabetes
Karl Sebastian Johansson, Andreas Brønden, Filip Krag Knop, et al.
Drugs & Aging
|
September 1, 2023
Methodological Considerations for Describing Medication Changes in Relation to Clinical Events and Death: An Applied Example in Patients with Type 2 Diabetes and Cancer
Karl Sebastian Johansson, Tonny Studsgaard Petersen, Mikkel Bring Christensen, et al.
Diabetes Care
|
July 12, 2024
Rational Pharmacotherapy in Type 2 Diabetes: Danish Data From 2002 to 2020 on Mortality, Diabetes- Related Outcomes, Adverse Events, and Medication Expenses
Karl Sebastian Johansson, Espen Jimenez-Solem, Tonny Studsgaard Petersen, et al.
Diabetes Care
|
May 6, 2024
Increasing Medication Use and Polypharmacy in Type 2 Diabetes: The Danish Experience From 2000 to 2020
Karl Sebastian Johansson, Espen Jimenez-Solem, Tonny Studsgaard Petersen, et al.
Expert Opinion on Drug Discovery
|
July 11, 2020
What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline
Karl Sebastian Johansson, David Peick Sonne, Filip Krag Knop, et al.
The Lancet. Healthy Longevity
|
December 2, 2023
Age disparities in glucose-lowering treatment for Danish people with type 2 diabetes: a cross-sectional study between 2019 and 2020
Karl Sebastian Johansson, Cille Bülow, Espen Jimenez-Solem, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 22, 2023
Physician-led medication reviews in polypharmacy patients treated with at least 12 medications in a type 2 diabetes outpatient clinic: A randomised trial
Karl Sebastian Johansson, Jonatan Kornholt, Cille Bülow, et al.
Ugeskrift for Laeger
|
December 15, 2020
[Local anaesthetic systemic toxicity]
Karl Sebastian Johansson, Lotte Christine Groth Høgberg, Mikkel Bring Christensen, et al.
Danish Medical Journal
|
April 29, 2022
Drug use in patients with short bowel syndrome and intestinal failure
Mette Medom Vorre, Karl Sebastian Johansson, Kristian Asp Fuglsang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Ugeskrift for Laeger
|
April 29, 2021
[Hypersexuality]
Katja Wium Geiker, Annamaria Giraldi, Karl Sebastian Johansson, et al.
Expert Opinion on Pharmacotherapy
|
February 29, 2020
Clinical pharmacology of imeglimin for the treatment of type 2 diabetes
Karl Sebastian Johansson, Andreas Brønden, Filip Krag Knop, et al.
Drugs & Aging
|
September 1, 2023
Methodological Considerations for Describing Medication Changes in Relation to Clinical Events and Death: An Applied Example in Patients with Type 2 Diabetes and Cancer
Karl Sebastian Johansson, Tonny Studsgaard Petersen, Mikkel Bring Christensen, et al.
Diabetes Care
|
July 12, 2024
Rational Pharmacotherapy in Type 2 Diabetes: Danish Data From 2002 to 2020 on Mortality, Diabetes- Related Outcomes, Adverse Events, and Medication Expenses
Karl Sebastian Johansson, Espen Jimenez-Solem, Tonny Studsgaard Petersen, et al.
Diabetes Care
|
May 6, 2024
Increasing Medication Use and Polypharmacy in Type 2 Diabetes: The Danish Experience From 2000 to 2020
Karl Sebastian Johansson, Espen Jimenez-Solem, Tonny Studsgaard Petersen, et al.
Expert Opinion on Drug Discovery
|
July 11, 2020
What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipeline
Karl Sebastian Johansson, David Peick Sonne, Filip Krag Knop, et al.
The Lancet. Healthy Longevity
|
December 2, 2023
Age disparities in glucose-lowering treatment for Danish people with type 2 diabetes: a cross-sectional study between 2019 and 2020
Karl Sebastian Johansson, Cille Bülow, Espen Jimenez-Solem, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 22, 2023
Physician-led medication reviews in polypharmacy patients treated with at least 12 medications in a type 2 diabetes outpatient clinic: A randomised trial
Karl Sebastian Johansson, Jonatan Kornholt, Cille Bülow, et al.
Ugeskrift for Laeger
|
December 15, 2020
[Local anaesthetic systemic toxicity]
Karl Sebastian Johansson, Lotte Christine Groth Høgberg, Mikkel Bring Christensen, et al.
Danish Medical Journal
|
April 29, 2022
Drug use in patients with short bowel syndrome and intestinal failure
Mette Medom Vorre, Karl Sebastian Johansson, Kristian Asp Fuglsang, et al.
Page
of 2